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dose-response trial (The QUADX-1 trial)
Rasmus Skov Husted1,2,3,4*, Anders Troelsen4, Kristian Thorborg1,2,5, Michael Skovdal Rathleff6,7, Henrik Husted4
and Thomas Bandholm1,2,3
Abstract
Background: Patients with knee osteoarthritis (OA) report knee pain, limitation in physical activities and low quality
of life. The two primary treatments for knee OA are non-surgical treatment (e.g., exercise) and surgery (total knee
arthroplasty (TKA)); however, national guidelines recommend non-surgical treatment to be tried prior to surgical
procedures. Patients with knee OA are characterized by decreased muscle strength, particularly in the knee-extensor
muscles. Correspondingly, decreased knee-extensor strength is found to be associated with an increased risk of
development, progression and severity of knee OA symptoms. Recent trials suggest a positive effect of pre-operative
exercise on pre- and post-operative outcome; however, the most effective pre-operative knee-extensor strength
exercise dosage is not known. The purpose of the present trial is to investigate the efficacy of three different exercise
dosages of pre-operative, home-based, knee-extensor strength exercise on knee-extensor strength before and shortly
after surgery in patients eligible for TKA due to end-stage knee OA.
Methods: In this randomized dose-response trial with a three-arm parallel design, 140 patients with end-stage knee
OA (candidates for TKA) are randomized to one of three exercise dosages (two, four or six session/week) of knee-
extensor strength exercise (three sets, 12 repetitions at 12 RM, per exercise session) for 12 weeks. The knee-extensor
strength exercise is home-based (unsupervised) and performed with an elastic exercise band following an initial
exercise instruction. Adherence is objectively quantified using a sensor attached to the exercise band. The primary
outcome will be the change in knee-extensor strength. Following the 12-week exercise period, the need for TKA
surgery is re-assessed by an orthopedic surgeon.
Discussion: Decreased knee-extensor strength is a major challenge in patients with knee OA. Exercise programs
focusing on knee-extensor strength are found to be more effective in relieving knee OA pain and symptoms
compared to more general exercise programs. However, the optimal exercise dosage for knee-extensor strength
deficits in patients with knee OA is inconclusive. Knowledge on the dose-response relationship for knee-extensor
strength exercise in patients with knee OA will help guide future non-surgical treatment in this patient population.
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Background
Patients diagnosed with knee osteoarthritis (OA) report
pain, low quality of life and limitation in physical activ-
ities [1]. As a consequence, in Denmark, around 8000
patients with end-stage knee OA receive surgical treat-
ment annually, in the form of total knee arthroplasty
(TKA), to overcome their knee-related disabilities [2].
Currently, the two primary treatments for knee OA are
non-surgical treatment (e.g., pain treatment, exercise
and weight loss if indicated) and surgery (TKA) [3].
There is preliminary evidence that pre-operative exercise
may postpone total hip arthroplasty in patients with hip
OA [4]. Likewise, pre-operative exercise in candidates for
TKA will provide an optimized basis for deciding whether
to commence TKA; e.g., patients experiencing pain relief
and functional improvement following exercise might bene-
fit from postponing their potential TKA and vice versa.
The latest systematic review on the efficacy of pre-operative
strength exercise to enhance post-operative recovery
after TKA and THA concludes that pre-habilitation
may slightly improve early post-operative pain and
function among patients undergoing total joint replace-
ment; but the effects are too small and short-lived to be
considered clinically important [5]. However, this con-
clusion is based on trials with significant limitations,
providing very low certainty in estimates [5].
Recently, the first randomized controlled trial investi-
gating the efficacy of TKA in patients eligible for TKA
was conducted [6]. It showed an added effect (pain relief
and functional improvement) of 30% by TKA and non-
surgical treatment to that achieved by non-surgical treat-
ment alone (30%). This highlights the importance of
coordinating non-surgical and surgical care to select the
right candidates for surgery, especially as patients under-
going TKA seem to experience more serious adverse
events compared to non-surgical treatment [6]. These
results suggest that non-surgical treatment should at
least be tried out and considered before commencing
surgical procedures. Optimally, patients awaiting TKA
would conduct home-based, pre-operative exercise as
the effect of exercise helps to establish the potential
need for a future orthopedic operation. At the same
time, it would be a potential solution of little cost and it
enables the patients to self-manage their symptoms.
Patients with knee OA are characterized by decreased
knee-extensor strength and this decrease in knee-extensor
strength is associated with limitation of activities of daily
living, independent of knee pain [7, 8]. Correspondingly,
knee-extensor muscle weakness is found to be associated
with increased risk of developing knee OA, progression of
knee OA, symptoms of knee pain and decline in function
[9, 10]. Clinically, patients diagnosed with end-stage knee
OA who are awaiting TKA to reduce pain and disability
are reported to have 35% reduced knee-extensor strength
compared to healthy, age-matched persons [7]. Shortly
after TKA, patients lose an additional 80% of their pre-
operative knee-extensor strength [11]. This massive loss in
knee-extensor strength severely limits functional perform-
ance and may delay hospital discharge in the large number
of patients undergoing TKA every year [12]. One of the
latest systematic reviews on the efficacy of exercise to re-
duce pain and disability in patients with knee OA showed
that isolated knee-extensor strength exercise was more
effective in reducing pain and disability if not combined
with other forms of exercises (e.g., other muscle groups or
cardiovascular training) [13]. In line with this, the 2014
international guidelines for non-surgical management of
knee OA include strength exercise of the knee-extensor
muscles [14].
Two recent randomized controlled trials have indicated
that high-volume, pre-operative strength exercise may
enhance pre- and post-operative knee-extensor strength
as well as functional performance in patients undergoing
TKA [15, 16]. Hence, there are indications that the applied
pre-operative exercise dose seems related to pre- and
post-operative efficacy, making a dose-response trial of
pre-operative exercise particularly relevant.
Purpose
The purpose of the present trial is to investigate the effi-
cacy of three different exercise dosages (two, four and
six exercise sessions per week) of pre-operative, home-
based, knee-extensor strength exercise on knee-extensor
strength before and shortly after surgery in patients eligible
for TKA due to end-stage knee OA.
Hypothesis
We hypothesize that a dosage of four knee-extensor
strength exercise sessions per week will elicit the
greatest strength increase pre-operatively compared to
two or six sessions per week. The recommended mini-
mum exercise dosage required for strength gains accord-
ing the American College of Sports Medicine is two
sessions per week [17]; therefore, two greater dosages are
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investigated and used as comparators. Four sessions per
week is likely optimal and six sessions per week probably
have no additional benefit, but could potentially increase
knee pain [18, 19].
Methods
Literature search and search matrix
Before commencing the planning of this trial, a system-
atic literature search was conducted to locate trials in-
vestigating the same research question or planning to do
so (protocols). The following search matrix (developed
using a PICOT approach [20]) was used to search
MedLine through pubmed.com on 18 November 2015
with weekly updated searches:
(((((((((((“end stage osteoarthritis”) or ((“Osteoarthri-
tis”[Mesh]) or “Osteoarthritis, Knee”[Mesh])) or osteo-
arthritis)))) or “knee osteoarthritis”[Title/Abstract]))
and (((((((((“resistance training”[Title/Abstract]) or
“Resistance Training”[Mesh]) or “strength training”[-
Title/Abstract]) or physiotherapy[Title/Abstract]) or
“Physical Therapy Specialty”[Mesh]) or “Physical Therapy
Modalities”[Mesh]) or “knee extensor training”[Title/Ab-
stract]) or “quadriceps training”[Title/Abstract]) or “pre-
operative training”[Title/Abstract]) or “physical function”[-
Title/Abstract])) and ((((((“pre-operative strength”[Title/
Abstract]) or “knee extensor strength”[Title/Abstract]) or
“quadriceps strength”[Title/Abstract]) or “Pain”[Mesh]) or
pain[Title/Abstract]) or “Musculoskeletal Pain”[Mesh]))
and (((((((“post-operative strength”[Title/Abstract]) or
“post-operative knee extensor strength”[Title/Abstract]) or
“knee extensor strength”[Title/Abstract]) or “quadriceps
strength”[Title/Abstract]) or “Pain”[Mesh]) or pain[Ti-
tle/Abstract]) or “Musculoskeletal Pain”[Mesh]) and
(((((((meta-analysis[Title/Abstract]) or “Meta-Analy-
sis”[Publication Type]) or “systematic review”[Title/
Abstract]) or “Review”[Publication Type]) or “random-
ized controlled trial”[Title/Abstract]) or “Randomized
Controlled Trial”[Publication Type]) or “prospective
cohort”[Title/Abstract]).
Systematic reviews and meta-analyses were found but
none specifically addressed the pre-operative effect on
muscle strength of a single knee-extensor strength exer-
cise in patients with knee OA. No Cochrane reviews
were found. An updated search was performed on 1
May 2017 providing new academic literature relevant for
the scope of this trial [21, 22].
Trial design
The trial is named the QUADX-1 trial. It uses a three-
arm, parallel-group, randomized trial design with three
intervention groups (exercise dosages) and no control
group. No control group is included as the primary
purpose of the trial is to investigate the dose-response
relationship of the investigated knee-extensor strength
exercise dosages. Based on the sample size estimation
outlined below, 140 patients will be randomized (1:1:1)
to one of three exercise dosages for 12 weeks. Out-
comes will be assessed blinded at baseline before the
start of the exercise (t0), after the exercise intervention,
which is before possible surgery (t1, primary end-
point), at hospital discharge 1–8 days after surgery (if
performed) (t2) and, finally, at 3 months after surgery
(if performed) (t3). A flow chart of the trial is pro-
vided below (Fig. 1).
This clinical trial protocol is based on the PREPARE
trial guide [23] and the SPIRIT Checklist (Fig. 2, Additional
file 1) [24]. The trial report will adhere to the Consolidated
Standards of Reporting Trials (CONSORT) Checklist using
the extension for non-pharmacological treatments [25].
The TIDieR Checklist will be used for intervention descrip-
tion (Additional file 2) [26]. The trial was pre-registered at
ClinicalTrials.gov on 10 October 2016 (ID: NCT02931058,
https://clinicaltrials.gov/ct2/show/NCT02931058) and ap-
provals with the Ethics Committee of the Capital
Region Denmark (ID: H-16025136) and the Danish
Data Protection Agency (J. nr.: 2012-58-0004. Lokale
RegH j. nr.: AHH-2016-072, med I-Suite nr.: 04980)
were obtained before the first patient was enrolled. The trial
will be conducted at Copenhagen University Hospital
Hvidovre and in the collaborating municipalities of
Copenhagen, Hvidovre and Brøndby, Denmark.
Recruitment
All patients will be included by consecutive sampling
from the orthopedic outpatient clinic at Copenhagen
University Hospital, Hvidovre. At the orthopedic out-
patient clinic, possible patients for TKA surgery due to
end-stage knee OA are introduced to the trial and of-
fered to participate by the orthopedic surgeon if they fit
the initial eligibility criteria (please see below). On the
same day, eligible patients interested in participating in
the trial are then referred to a research assistant who
provides thorough oral and written information about
the trial. Eligible patients are informed that participation
in the project includes 12 weeks of home-based, knee-
extensor strength exercise with the purpose of improving
knee-extensor strength, relieving knee pain and improving
functional performance. Further, they are informed that
after the exercise period, they will be re-assessed at the
orthopedic outpatient clinic with regards to undergo sur-
gery or not. To prevent performance bias, eligible patients
are blinded to the exercise dosage randomization as well
as the trial hypothesis. Information about the trial is pro-
vided in a calm setting dedicated to the trial. Should the
patients wish for a companion to be present during the
information meeting a new information appointment is
scheduled. Along with the information, a second more
thorough screening of inclusion and exclusion criteria is
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commenced. The patients are given a minimum of 24 h
to decide whether they would like to participate in the
trial or not. If the patients decide to participate, a base-
line assessment is scheduled. Written informed consent
is obtained at the baseline assessment. Once written in-
formed consent and baseline assessment is completed,
the patient is fully included in the trial. Outcome
assessments will be performed blinded by the primary
Fig. 1 Flow chart of enrollment, randomization, treatment and follow-up
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investigator and a research assistant dedicated to the trial,
who are both trained according to the trial outcome-
assessment protocol to ensure standardized assessments
throughout the trial. To further refine and ensure
standardization of the trial outcome-assessment protocol
we piloted the outcome-assessment procedures in seven
patients prior to initiating the trial.
Eligible criteria
Inclusion criteria
 Patient is a possible candidate for a primary TKA
due to knee OA, based on the below terms:
◦ Knee pain ≥ 3 (Numeric Rating Scale) in the last
week
◦ Kellgren-Lawrence classification grade ≥ 2
 Patient is eligible for home-based, knee-extensor
strength exercise
 Patient is age ≥ 45 years
 Patient is resident in one of the three municipalities
(København, Hvidovre or Brøndby) involved in the trial
 Patient is able to speak and understand Danish
Exclusion criteria
 Exercise is contra-indicated for the patient
 Patient has a neurological disorder
 Patient has a diagnosed systemic disease (American
Society of Anesthesiologists’ physical status classification
score (ASA) ≥ 4)
 Patient with terminal illness
 Patient has severe bone deformity demanding use of
non-standard implants
 Weekly alcohol consumption above national
recommendations (>7 units for women, > 14
units for men)
Fig. 2 Schedule for enrollment, intervention and outcome assessments (Standard Protocol Items: Recommendations for Interventional
Trials (SPIRIT))
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Protocol amendments
 8 February 2017: Inclusion criteria age changed
from ≥ 50 years to ≥ 45 years. The rationale for this
modification is that patients aged 45–49 years with
knee OA who are possible candidates for TKA are
likely to benefit from participation. Recent
comparable trials of pre-operative exercise on the
same population had age-related inclusion criteria
including the age-span of 45–49 years of age [27, 28]
 8 February 2017: Exclusion criteria ASA score
changed from ≥ 3 to ≥ 4. The rationale for changing
the exclusion criteria relating to the ASA score is
that patients with knee OA and an ASA score of 3
who are possible candidates for TKA are likely to
benefit from participating in the trial. An ASA score
of 3 is defined as “A patient with severe systemic
disease,” while an ASA score of 4 is defined as “A
patient with severe systemic disease that is a constant
threat to life” [29]. One definition-difference between
ASA score 3 and 4 is the functional capacity, where
a patient with an ASA score of 3 is able to complete
a flight of stairs or walk 200 m on level ground,
whereas a patient with an ASA score of 4 is not able
to do this [29]. Thus, patients with knee OA and an
ASA score of 3 who are possible candidates for TKA
are able to participate in the present exercise trial
 30 March 2017: Inclusion criteria knee pain
(Numeric Rating Scale (NRS)) in the last week
changed from > 3 to ≥ 3. The rational for changing
the NRS from > 3 to ≥ 3 is that some patients who
are considered candidates for total knee replacement
might not have pain scores higher than 3. Thus,
they might end up being excluded from the trial
even though they are clinically considered
candidates for total knee replacement. Hence, this
change was made to reflect current clinical practice
 30 March 2017: Inclusion criteria Oxford Knee Score
(OKS) was removed as an inclusion criterion but
still kept as a descriptive and effect outcome. The
rationale for this modification (removing OKS as an
inclusion criteria) is that OKS is not used in daily
clinic practice as a means of assessing whether a
patient is a candidate for TKA or not. Thus, keeping
the OKS as an inclusion criterion in the QUADX-1
trial will not reflect current clinical practice
 All the above protocol amendments are approved by
the Ethics Committee of the Capitol Region
Denmark (ID: H-16025136; 55528, 55529, 57312)
Intervention
Once the baseline assessment is completed, the patients
are referred to their local municipality rehabilitation set-
ting for knee-extensor strength exercise instruction. The
initial exercise instruction takes place there, where the
patients are received by a trial-dedicated physiotherapist
who is specialized in instructing and training patients
with knee OA. Once the instruction is completed and
the patients are comfortable with the exercise, an exer-
cise session is completed under supervision from the
physiotherapist. The patients are handed personal elastic
exercise bands for exercise at home and a study-specific
brochure where instruction notes to the exercise are
illustrated and described (Additional file 3). All the phys-
iotherapists dedicated to the trial were trained by the
primary investigator prior to the start of the trial to en-
sure standardized exercise instruction and information
across the physiotherapists.
The intervention period is 12 weeks. After 4 and
8 weeks of exercise, the patients have an exercise quality
check-up (booster visit) with the physiotherapist in the
municipality setting. The exercise quality check-up in-
cludes exercise technique re-assessment (fractional and
temporal distribution of the contraction modes, range of
motion and positioning), ensuring optimal length or type
of elastic exercise band (resistance corresponding to 12
repetitions-maximum (RM)) and exercise-related ques-
tions from the patients.
Three exercise dosages are investigated; two, four and
six sessions per week for 12 weeks (group 2, 4 and 6, re-
spectively) (Table 1). Each exercise session comprises a
single-strength training exercise, knee-extension, which
is performed in three sets with 12 repetitions at a load
corresponding to 12 RM in each set. There is no control
group. The patients are randomly allocated to one of the
three exercise dosages. The patients are instructed to
perform only one exercise session per day. That is, they
are not allowed to combine several exercise sessions on
the same day. For example, patients randomized to group
6 are instructed to exercise 6 days of the week.
The intervention is personalized to the extent where
each patient is exercising with an individual absolute re-
sistance in the elastic exercise band corresponding to a
relative load of 12 RM. Contractions should be continued
until volitional muscular failure. That is, until the knee-
extensor muscles are maximally fatigued and the patient is
not able to perform further repetitions. If volitional mus-
cular failure occurs before 12 RM, the resistance of the
elastic band is adjusted so that the pre-determined num-
ber of repetitions can be completed. Whenever a given
resistance in the elastic exercise band becomes too low
(i.e., more than 12 repetitions per set can be performed),
the patients are instructed to adjust the resistance in the
elastic exercise band (increase the distance between the
two endpoints of the elastic exercise band, i.e., moving the
chair further away from the door (Fig. 3)) to achieve a
new resistance corresponding to a relative load of 12
RM. The home-based, knee-extensor strength exercise
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(Fig. 3 and Fig. 9, Supplementary online video [30]) is de-
scribed in detail below (Table 2) according to the mechano-
biological descriptors from Toigo and Boutellier [31].
Criteria for modifying and discontinuing
Criteria for discontinuing
Patients are instructed to stop exercising if they experience
a strong flare up or a strong aggravation of knee-related
symptoms (e.g., pain and swelling), i.e., knee-related symp-
toms that are intolerable for the patient. Correspondingly,
patients are encouraged to complete the exercise if they
experience minor and moderate knee-related symptoms
[32]. Should the patients experience intolerable symptoms
(stopping with exercise); they are provided with a telephone
number to a physiotherapist (the trial manager) and are en-
couraged to call. The trial manager fills out a standardized
form at these calls.
Criteria for modifying
Should the patients experience strong knee-related
symptoms, they are instructed to lessen the resistance in
the elastic exercise band (shortening the distance be-
tween the endpoints of the elastic exercise band, i.e.,
moving the chair closer to the door (Fig. 3)). Importantly
though is that this reduced resistance in the elastic exer-
cise band does not comprise the exercise resistance cor-
responding to 12 RM, (i.e., too little resistance in the
elastic exercise band). This is explained to the patients
at the exercise instruction session and mentioned in the
brochure handed to the patients along with the elastic
exercise band (Additional file 3).
Participant compliance, retention and concomitant care
At the baseline outcome assessment and at the exercise
instruction session the patients are encouraged to
complete the full intervention and the patients are
handed an information brochure about both how to con-
duct the exercise, with encouragement to complete the
intervention and with information on how to handle
kinesiophobia (Additional file 3). Further, the patients
have two exercise quality check-up visits (booster visits):
one at 4 weeks and one at 8 weeks, with the physiother-
apist in the municipality setting. These booster visits
also serve as promoters for exercise adherence. The pa-
tients should continue their lives without changing any
concomitant care or interventions, except extra exercise
of the quadriceps muscle. For pain relief the patients are
allowed use of non-steroidal anti-inflammatory drugs
(NSAIDs) and other pain-reducing products (cf. the
Danish National Guidelines for knee OA [3]), as they
would normally do, not needing a physician’s prescription.
Outcomes
The trial is designed with four pre-determined outcome
assessments; at baseline (week 0) (t0), after 12 weeks of
home-based exercise (2–8 days after the final exercise
session), corresponding to the endpoint before surgery
(t1), at hospital discharge 1–8 days after surgery (t2)
(provided surgery is performed) and finally, 3 months
after surgery (t3) (Fig. 2) (provided surgery is performed).
The primary endpoint is after the intervention period
(t1). Secondary endpoints of interest are just before hos-
pital discharge 1–8 days after surgery (t2) and 3 months
after surgery (t3).
Table 1 Exercise sessions per week according to exercise dosage randomization
Dosage groups Sessions/week
Gp. 2 – 2 sessions/week 3*12 RM 3*12 RM
Gp. 4 – 4 sessions/week 3*12 RM 3*12 RM 3*12 RM 3*12 RM
Gp. 6 – 6 sessions/week 3*12 RM 3*12 RM 3*12 RM 3*12 RM 3*12 RM 3*12 RM
Knee-extensor exercise dosages investigated
Fig. 3 The home-based, knee-extensor strength exercise
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Primary outcome
Change in isometric knee-extensor strength from baseline
(week 0) to after the intervention period (> 12 weeks).
Knee-extensor strength is chosen as the primary outcome
for the following reasons. Firstly, it is an outcome closely
related to the exposure (strength training), which we
consider important in a dose-response trial, because other
health effects are likely mediated via increased knee-
extensor strength. Secondly, knee-extensor strength is
associated with the development and progression of knee
OA and knee pain and function [9, 10], and as such, we
also consider the outcome, a surrogate measure for the
Table 2 Exercise description
Brief name Home-based, knee-extensor
strength exercise
Detailed and practical demonstration
of the exercise can be accessed
via this online video [30]
1. Load magnitude Corresponding to 12 repetitions maximum (RM)
2. Number of repetitions 12
3. Number of sets 3
4. Rest between sets Minimum 30 s, or until sufficiently recovered from previous set
5. Number of exercise interventions Group 2 (2 sessions per week)
Group 4 (4 sessions per week)
Group 6 (6 sessions per week)
6. Duration of the experimental period 12 weeks
7. Fractional and temporal distribution of the contraction modes per
repetition and duration (s) of 1 repetition
Concentric phase (3 s)
Isometric phase (1 s)
Eccentric phase (4 s)
Total duration of 1 repetition (8 s)
8. Rest between repetitions None, that is, right after finishing one repetition the next is commenced
9. Time-under-tension (TUT) Repetition TUT (8 s)
Set TUT with 12 repetitions (1 min, 36 s)
Session TUT (3 sets × 12 repetitions) (4 min, 42 s)
10. Volitional muscular failure No, but contractions should be continued until volitional muscular
failure is very close. That is, until the knee-extensor muscles are
maximally fatigued and the patient is not able to perform further
repetitions. If volitional muscular failure occurs before the 12 RM,
the resistance of the elastic band is adjusted so that the pre-determined
number of repetitions can be completed
11. Range of motion Starting position: 80–90° of knee flexion (0 = full extension)
End-range of motion position: 0–10 (as close to full extension as possible)
12. Recovery time between exercise sessions Group 2: 3 days
Group 4: 1 day
Group 6: 0 days
13. Anatomical definition of the exercise (exercise form) The knee-extensor strength exercise is performed sitting in a stable
chair. Sitting position in the chair is determined by the distance from
the edge of the seat to the back of the knee; this distance should
be 2–3 cm. If possible, the back rest can be used as well as the armrest.
If the chair is without an armrest one can hold at the (side) edge of the
seat. To ensure that the foot is free of the floor at 80–90° of flexion an
object (e.g., a pillow) is placed under the thigh (Fig. 3). The elastic
exercise band is fixated to an immoveable object (e.g., an elastic exercise
band anchor behind a closed door) and wrapped around the ankle of
the exercised leg (Fig. 9).
Starting position: The exercise leg is relaxed with 80–90° of flexion
(0 = full extension)
Concentric phase: The exercise leg is extended as much as possible
towards full extension using 3 s
Isometric phase: The extended position is held for 1 s
Eccentric phase: Slow controlled flexion of the knee joint (4 s) until
the knee joint is flexed 80–90°
These slow movements are chosen to ensure long time-under-tension
(TUT) in the muscle
The home-based, knee-extensor strength exercise described in detail according to the mechano-biological descriptors from Toigo and Boutellier [31]
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development and progression of knee OA, knee pain and
function.
Secondary outcomes
Change in performance-based function (walking dis-
tance in 6 min and climbing of stairs), current knee
pain and during the last week (numerical rating scale),
self-reported disability (Knee Osteoarthritis Outcome
Score and Oxford Knee Score) as recommended by
Osteoarthritis Research Society International [33, 34],
need for surgery and exercise adherence (sessions, sets,
reps, TUT).
Other outcomes
Registration of adverse events (adverse event, number of
adverse events in each group (surgery/no surgery).
At outcome assessment endpoint t2 (after surgery at
hospital discharge) only the outcomes isometric knee-
extensor strength, 6-Minute Walking Test (6MWT), SCT
and current knee pain are assessed. The KOOS and OKS
questionnaires as well as knee pain during the last week
are omitted at this endpoint as they are not validated to
assess acute post-operative conditions, and use too long
a recall period.
Elaborated description of outcome measures
Primary outcome
Isometric knee-extensor strength The measurement
will be assessed using a computerized strength chair (Good
Strength Chair, Metitur Oy, Jyvaskyla, Finland). This is a
valid (0.78–0.92) and reliable (inter-trial 0.98–1.00 (stand-
ard error of measurement (SEM) < 10%), inter-evaluator
0.92–0.99 (SEM 8.34–9.92%)) knee-extensor strength
measure in the TKA population [35].
Prior to outcome assessment, the patients will be
informed about the procedure. The measurement con-
sists of five maximal isometric knee-extensor contrac-
tions at 60° knee flexion separated by a 60-s pauses.
The highest obtained value will be used for analysis.
The patients are instructed to extend their knee as
forcefully as possible with a gradual increase in force
over a 5-s period. There will be strong and standard-
ized verbal encouragement during each contraction.
Knee-extensor strength will subsequently be expressed
as the maximal voluntary torque per kilogram body
mass (Nm/kg) using the external lever arm and body
mass of each patient. Results will be presented, firstly,
as absolute changes (Nm/kg) and, secondly, as relative
changes (%) from baseline.
Secondary outcomes
6-Minute Walking Test for distance (6MWT) The
6MWT measures the maximal distance a patient is able
to walk in 6 min between two cones placed 29 m apart
from each other. The measurement has previously been
found to be reliable (intraclass correlation coefficient
(ICC)2,1 0.97, SEM 13.0 m) [36] and responsive [37] in
the TKA population.
The patients are instructed to walk as long a distance
as they can in six minutes. They will be encouraged to
walk as fast as possible but are not allowed to jog or
run. The patients are allowed to rest standing or leaning
against a wall during the six minutes but the time will
be running. Walking aids are allowed if needed. At each
minute the patients will be informed of the time.
Stair Climb Test (SCT) The SCT measures the time
(seconds) it takes to ascend and descend an 11-step
flight of stairs with 16-cm step height. The stair has a
handrail on both sides. The SCT has been found to be
reliable in the TKA population (inter-tester ICC2,1 0.94–
0.96, SEM 1.14 s, minimal detectable change (MDC)90
2.6 s) [38]. The patients are instructed to ascend and
descend an 11-step flight of stairs as fast as possible, but
in a safe manner. Use of hand rail and walking aid is
permitted. The patients are allowed to rest during the
measurement but the time keeps running.
Knee Osteoarthritis Outcome Score (KOOS) The
KOOS is a 42-item questionnaire regarding knee function.
The questionnaire is comprised of five subscales (symptoms
(7), pain (9), function, daily living (17), function, sports and
recreational activities (5) and quality of life (4). Each ques-
tion has standardized answer options with five options at
each question (Likert scale, 0–4). After normalization of
the answers each subscale scores from 0–100 (100 indicat-
ing no symptoms). The KOOS questionnaire is found to be
reliable in all subscales (pain ICC 0.8–0.97, SEM 7.2–10.2;
symptoms ICC 0.74–0.94, SEM 7.2–9.0; daily living ICC
0.84–0.94, SEM 5.2–11.7; sports ICC 0.65–0.92, SEM 9–
24.6; quality of life ICC 0.6–0.91, SEM 7.4–10.8) [39]. The
KOOS questionnaire is also found be to reliable in the
TKA population [40].
Oxford Knee Score (OKS) The OKS is a 12-item ques-
tionnaire regarding knee-related function and pain in
patients with knee OA. Each question has five answer
options (Likert scale, 0–4). The OKS demonstrates
good test-retest reliability for both the summary scale
(ICC 0.93, MDC90 + 6), pain (ICC 0.91, MDC90 ± 16)
and function (ICC 0.92, MDC90 ± 15) component
subscales [41].
Knee pain Individual knee pain is assessed with the Nu-
meric Rating Scale (NRS). This is an 11-point subjective
pain scale ranging from 0–10 (0 indicating no pain). In
this trial, the patients will be asked about their knee pain
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related to two endpoints: (1) knee pain right now and
(2) during the last week. The question is asked in the
following manner “on a scale from 0 to 10 where 0 indi-
cates no pain and 10 indicates worst imaginable pain,
how much knee pain do you have (1) right now and (2)
how much knee pain have you had in the last week
(index knee)?” The patients are asked while seated in a
chair with 70–90° of knee flexion (standardized). The
NRS is found to have the strongest face validity com-
pared to other pain measurement scales (Visual Analog
Scale and Verbal Descriptor Scale) in surgical patients
after surgery as well as high construct and criterion
validity [42]. The NRS is also found to be reliable both
before (ICC 0.82) and in the first 1–6 days following
surgery (ICC 0.673–0.783) [43]. A minimal clinically im-
portant difference in pain relief post orthopedic surgery
has previously been suggested to be 35% [44].
Surgical status – Need for surgery? At the second out-
come assessment (after the 12-week exercise period (t1))
the patients are asked by the outcome assessor “based
on your knee symptoms in the last week would you say
that you need knee surgery?” The outcome assessor is a
physiotherapist with insight to the knee OA condition.
The answer will be categorized into one of three options:
(1) “yes” I believe I need surgery, (2) I do not know or (3)
“no” I do not believe I need surgery.
Exercise adherence A large challenge regarding home-
based exercise is that adherence to home-based exercise
is reported to be poor [45–48], suggesting low effect
of the exercise interventions. To take into account
the possibility of non-adherence to the intervention
(which could distort the possible conclusion that the
intervention did not work), we will objectively quan-
tify exercise adherence. Adherence to the home-
based, single knee-extensor strength exercise will be
assessed using a sensor (BandCizer technology) at-
tached to the elastic exercise band used for the knee-
extensor strength exercise. The sensor stores data on
date, time, number of sets, repetitions, tonnage (kg ×
repetitions) and TUT. This elastic exercise band sen-
sor technology has been reported to be valid [49] and
reliable (ICC > 0.99) [50] for quantification of total
repetition, single repetition and contraction specific
TUT of an unsupervised exercise intervention.
In the present trial, patients are defined as adherent
to the exercise intervention if > 75% of the prescribed
exercise sessions are completed. Correspondingly, 1.5
sessions/week must be completed in group 2, three
sessions/week in group 4 and 4.5 sessions/week in
group 6. After the 12-week exercise period, the pa-
tients who undergo surgery are encouraged to con-
tinue exercising (same dosage) until the day of
surgery. The exercise adherence during this period will
also be quantified by use of the sensor. Patients decid-
ing not to undergo surgery following the 12 weeks of
exercise are encouraged to keep exercising, but exer-
cise adherence will not be quantified. Figure 4 shows
an example of objectively quantified exercise adher-
ence via the sensor attached to the elastic exercise
band. The example shows a knee-extensor strength
exercise session composed of three sets with 12 repeti-
tions in each set resulting in 36 repetitions in total for
the exercise session. Number of repetitions, total
TUT, mean TUT for the 36 repetition and the corre-
sponding standard deviation can be extracted. This is
also possible for single exercise sets (Fig. 5).
Adverse events All adverse events occurring while the
patients are enrolled in the trial will be recorded regard-
less of their relation to the exercise intervention, surgery
Fig. 4 Objective quantification of exercise adherence for a full exercise session comprising three sets of 12 repetitions
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or occurrence likely not related to the trial. Thus, an ad-
verse event can both be a negative effect of the interven-
tion, surgery or an occurrence not related to the trial,
that is an untoward occurrence during the trial which
may or may not causally related to the intervention or
trial. Regardless of a relation to the trial, all adverse
events are recorded and reported.
Finally, a qualitative study will be embedded in the trial.
Semi-structured interviews will be performed with ran-
domly selected participating patients both before and after
the trial about their experienced enablers and barriers re-
lated to the knee-extensor strength exercise and adherence
to the home-based intervention. The orthopedic surgeons
allocated to the trial will also undergo semi-structured in-
terviews about their experienced enablers and barriers with
the non-surgical, pre-operative, home-based intervention
both before and after the trial. The physiotherapists allo-
cated to the trial will undergo focus interviews, both before
the trial is commenced and once the trial is completed, to
explore their experienced enablers and barriers related to
administering the home-based intervention. This embed-
ded qualitative study is undertaken to refine the home-
based intervention for future trials and clinical imple-
mentation. This knowledge can then be used to design
a context-specific implementation plan, given a positive
trial outcome. The embedded qualitative study will be
reported in a separate qualitative paper, with a clear ref-
erence to the QUADX-1 trial.
Regular auditing is planned during the trial. Regular
meetings between the primary investigator, the ortho-
pedic department, the municipalities and the research
team will allow for checking of treatment notes and out-
come assessment forms for fidelity to protocol which
allows for addressing deviations.
Sample size
For a three-group-level One-way ANOVA of a normal
mean difference with a two-sided significance level of
0.05, a common standard deviation of 0.22 Nm/kg (iso-
metric knee-extensor strength measurement) [51], and a
minimal clinically important difference of 0.15 Nm/kg
(15%), a sample size of 126 (42 per group) patients is re-
quired to obtain a power of 80%. To allow for a dropout
rate of 10%, we will include 140 patients in total for the
intention-to-treat (ITT) analysis (3 × 42 + 14 = 140).
Randomization
The patients will be randomly assigned to one of the
three intervention groups (two, four or six sessions per
week) by a 1:1:1 allocation ratio. The generation of the
allocation sequence will be attended to by a statistician
not involved in the trial in any other way. One hundred
and forty opaque and sealed envelopes will be generated.
After being included in the trial (signed written in-
formed consent and completion of baseline assessment)
a person independent of the trial will open one of these
envelopes and inform the patient’s municipality which of
the three exercise groups the patient is allocated to. In
this way, the allocation information is kept secret from
the outcome assessor.
Blinding
The primary investigator collecting the outcomes (out-
come assessor) as well as the data analysts will be
blinded to allocation. At outcome assessment sessions,
the outcome assessor will start by informing the patients
that they are not allowed to mention what exercise dosage
they have received. The data will be coded in such a way
that group allocation is concealed in the dataset, thus
blinding the outcome assessors and data analysts to the
group allocation. The patients and the physiotherapists
instructing in the intervention will not be blinded due to
the nature of the intervention; however, the patients will
be blinded to the exercise dosages in the other groups,
which exercise dosages will be compared in the analysis
and which dosage is hypothesized to have the largest
Fig. 5 Objective quantification of exercise adherence for a single exercise set of 12 repetitions
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effect. Unblinding will only happen in the case where the
wellbeing a the patient is at risk. This will be assessed in
collaboration with the patient’s physician.
Data management
Data from the isometric knee-extensor strength assessment
are stored on a computer dedicated to the Metitur equip-
ment as well as being recorded in handwriting in a
standardized Case Report Form. The self-reported ques-
tionnaires (KOOS and OKS) will be filled in by the patients
in paper formats, as this is the way these questionnaires are
designed to be filled in. All data from the functional
(6MWT and SCT) and pain (NRS) assessments will be
recorded on a standardized Case Report Form by the
outcome assessor.
Data on exercise adherence from the sensors is
saved continuously on the built-in SD card. After the
intervention period, the sensors are collected and the
exercise data are transferred by Bluetooth from the
SD card onto a secure server. The device will not
contain any personal data.
Following all outcome assessments, data will be en-
tered into the browser-based research database Research
Electronic Data Capture (RedCap 7.1.1) by trial personal
using blinded double-data entry to ensure data quality.
To further ensure the integrity of the data, anonymous
ID numbers will be applied and data quality, data range
and data values will be checked to minimize typing er-
rors. All original written information and case report
forms will be stored in a secure locker and saved for 3
after the completion of the trial at the trial location. All
electronic data will be anonymous (patient IDs), coded
and saved on a secure server in the Capital Region of
Denmark.
Statistical analysis
Analysis outline
Three groups; group 2 = two sessions/week, group 4 = four
sessions/week and group 6 = six sessions/week. There is
no control group. The primary outcome is the change in
isometric knee-extensor strength. Time from baseline to
after 12 weeks of exercise is the primary endpoint (Δt0-t1)
and time from baseline to just before hospital discharge,
and time from baseline to 3 months after surgery are the
secondary endpoints (Δt0-t2 and Δt0-t3, respectively). The
analysis plans for the primary and secondary analyses are
outlined in Table 3.
Primary analysis
The primary analysis will be between-group contrasts for
the primary outcome at the primary endpoint. Figure 6 il-
lustrates a hypothetical presentation of changes in isomet-
ric knee-extensor strength at the primary endpoint for the
three groups.
Secondary analyses
The secondary analyses will be between-group contrasts
for the secondary outcomes at the primary and second-
ary endpoints. Figure 7 illustrates a hypothetical presen-
tation of changes in isometric knee-extensor strength for
the three groups during the whole trial period.
For all outcomes (primary and secondary), mean
scores with corresponding standard deviations (SD), and
between-group contrasts (change scores) with corre-
sponding 95% confidence intervals (95% CI) and p value,
will be reported at each endpoint (t0, t1, t2 and t3) for
each group (groups 2, 4 and 6) (Table 4).
The patients who choose not to be operated with TKA
after the exercise period will be followed with annual
outcome assessments as part of a small case study.
Descriptive statistics for the trial population will be
presented as in Table 5.
Supplementary analyses
The supplementary analyses will be simple regression
models in which the three exercise dosage groups will be
pooled, allowing us to utilize the full dataset; that is, the
exercise dosage recorded by the sensors will be used in
the analysis, not the prescribed exercise dosage. The
dependent variables will be the change in primary and
secondary outcomes from baseline to the primary end-
point and to the secondary endpoints. The independent
variable will be exercise dosage, quantified in two ways:
(1) as total TUT and (2) as number of completed exer-
cise sessions for each patient (Table 6). Figure 8 illus-
trates a hypothetical simple regression model with the
change in isometric knee-extensor strength (Nm/kg) at
the primary endpoint and TUT.
Missing data
All analyses will follow the intention-to-treat (ITT)
principle with a clear registration and reporting of the
drop-out rate. All patients will be analyzed as random-
ized. To create a full analysis dataset for the intention-
to-treat analyses, missing data will be imputed using
multiple imputations.
Data monitoring
As the intervention(s) provided in the present trial poses
little or no risk to the participating patients, no data moni-
toring committee will be composed. Funding sources of
the current trial has no part in the design, conduc-
tion or reporting of the trial, thus there is no con-
flict of interests. As the intervention(s) poses little
or no risk to the participating patients no interim
analyses will be applied. Stopping guidelines for dis-
continuing and modifying the exercise has been de-
scribed previously (see the “Criteria for modifying
and discontinuing” section).
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Table 3 Analysis outline for primary and secondary analysis
Variable/outcome Hypothesis Outcome measure
(unit, scale)
Methods of analysis
Descriptive statistics (sample characteristics) Age, weight, height, side of
index knee (continuous and
dichotomous)
Summary statistics
Primary analysis
Primary outcome
1. Change in isometric knee-extensor strength Δt0-t1 Group 2 < Group 4
Group 4 ≈ Group 6
Change in Nm/kg
(continuous)
Analysis of variance
ANOVAa
Secondary analysis
Secondary outcomes
2. Change in isometric knee-extensor strength
Δt0-t2, Δt0-t3
Group 2 < Group 4
Group 4 ≈ Group 6
Change in Nm/kg
(continuous)
ANOVAa
3. Change in Knee Osteoarthritis Outcome
Score (KOOS) subscales Δt0-t1, Δt0-t3
Group 2 < Group 4
Group 4 > Group 6
Change in questionnaire
subscales (continuous)
ANOVAa
4. Change in Oxford Knee Score (OKS) Δt0-t1, Δt0-t3 Group 2 < Group 4
Group 4 > Group 6
Change in questionnaire
(continuous)
ANOVAa
5. Change in 6-Minute Walking Test for distance
(6MWT) Δt0-t1, Δt0-t2, Δt0-t3
Group 2 < Group 4
Group 4 > Group 6
Change in meters walked
(continuous)
ANOVAa
6. Change in Stair Climb Test (SCT) Δt0-t1, Δt0-t2, Δt0-t3 Group 2 < Group 4
Group 4 > Group 6
Change in time used to
ascend and descend stairs
(continuous)
ANOVAa
7. Change in current knee pain (Numeric Rank
Scale, NRS) Δt0-t1, Δt0-t2, Δt0-t3
Group 2 < Group 4
Group 4 > Group 6
Change in NRS 0–10
(continuous)
ANOVAa
8. Change in knee pain during the last week
(Numeric Rank Scale, NRS) Δt0-t1, Δt0-t3
Group 2 < Group 4
Group 4 > Group 6
Change in NRS 0–10
(continuous)
ANOVAa
9 Distribution in need for surgery Group 2 < Group 4
Group 4 > Group 6
Yes, don’t know, no Summary statistics
Other outcomes
10. Difference in adherence to intervention
between groups
Group 2 > Group 4
Group 4 > Group 6
Group 2 > Group 6
We hypothesize differences between
groups in adherence (%) to the training
intervention (i.e., higher number of
sessions per week, the lower adherence (%))
Number of sessions,
sets, repetitions and time-
under-tension
ANOVAa
aIf data are not normally distributed the non-parametric Kruskal-Wallis test will be used
Analysis of variance: (ANOVA)
Fig. 6 A hypothetical presentation of group changes from baseline
to the primary endpoint (after 12 weeks of exercise) for the primary
outcome, knee-extensor strength
Fig. 7 A hypothetical presentation of group changes in knee-extensor
strength over the whole trial period. NB, control data are from the
academic literature [11] and so are the healthy, age-matched, control
data (age 66.8 years (6.5 SD)) [7]
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Access to the final trial dataset
The principal investigator and principal supervisor will
have full access to the dataset as well as all co-authors.
A fully patient-anonymized dataset and corresponding
statistical analysis code will be made available for the
scientific journal reviewing the manuscript and its re-
sults within 6 months in line with the recent proposal
from the International Committee of Medical Journal
Editors (ICMJE) [52].
Ancillary and post-trial care
The current trial is not planned to include patient ancillary
care or post-trial care. On completion of the trial, if partici-
pants want to continue with the exercises independently
they can do so. However, this will not be a part of the trial
and will be on the patient’s own initiative.
Dissemination policy
The QUADX-1 trial is planned to be reported in three
manuscripts, which will be published in scientific peer-
reviewed journals. All manuscripts will refer to the
QUADX-1 trial’s Clinical.Trials.gov identifier. The first
manuscript will be the trial protocol, the second manu-
script will be the primary trial report of the investigated
dose-response relationship, and the third manuscript will
be a qualitative study investigating enablers and barriers
for patient adherence to home-based exercise and phys-
iotherapists’ experience in administering home-based
exercise before TKA. The results will also be presented
at relevant scientific conferences and symposiums. Trial
participants will be informed of the trial via a letter
explaining the results in layman’s terms. On request, the
data underlying the results presented in the manuscript
will be available to reproduce the findings. We intend to
make the dataset – containing de-identified individual
patient data – publicly available no later than 6 months
after publication, consistent with the recent proposal
from the International Committee of Medical Journal
Editors (ICMJE) [52], if it complies with national
Table 4 Outcomes for primary and secondary analyses
t0
Baseline
t1
After 12-week
exercise
t2
After surgery at
hospital discharge
t3
3 months after
surgery
Between-group contrasts
(change scores) 95% CI (p)
Mean, SD Gp. 2 Gp. 4 Gp. 6 Gp. 2 Gp. 4 Gp. 6 Gp. 2 Gp. 4 Gp. 6 Gp. 2 Gp. 4 Gp. 6
Isometric knee-extensor
strength (Nm/kg)
Primary analysis Δt0-t1
Secondary analysis Δt0- t2, t0-t3
6-Minute Walking Test for
distance (6MWT)
Secondary analysis Δt0-t1,
Δt0-t2, Δt0-t3
Stair Climb Test (SCT) Secondary analysis Δt0-t1,
Δt0-t2, Δt0-t3
Knee Osteoarthritis Outcome
Score (KOOS)
Na Na Na Secondary analysis Δt0-t1,
Δt0-t3
Oxford Knee Score (OKS) Na Na Na Secondary analysis Δt0-t1,
Δt0-t3
Current knee pain (Numeric
Rating Scale (NRS) 0–10)
Secondary analysis Δt0-t1,
Δt0-t2, Δt0-t3
Knee pain during the last
week (NRS 0–10)
Na Na Na Secondary analysis
Δt0-t1, Δt0-t3
Need for surgery now
(yes/don’t know/no) Na Na Na Na Na Na Na Na Na Secondary analysis
Exercise adherence
• No. sessions (prescribed,
completed, % completed) Na Na Na Na Na Na Secondary analysis
• Seconds of total time-under-
tension (TUT) (prescribed,
completed, % completed) Na Na Na Na Na Na Secondary analysis
Adverse events Secondary analysis
Table 5 Descriptive statistics
Gp. 2 Gp. 4 Gp. 6 All patients
Age (years)
Height (cm)
Weight (kg)
Gender (m/f)
Index knee (r/l)
Kellgren-Lawrence classification (I–IV)
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regulations, e.g., the Danish Data Protection Agency.
Trial data can be requested by contacting the main in-
vestigator (RSH) or trial director (TB). Positive as well
as negative and inconclusive results will be published.
All contributors to the study will be offered to co-
author the three above manuscripts if they fulfill the
International Committee of Medical Journal Editors
(ICMJE) recommendations for authorship [52]. No pro-
fessional writers will be used.
Discussion
In 2011, approximately 60,000 patients were registered
in the Danish health care system with symptoms of knee
OA and the annual incidence of knee OA has increased
from 35.8 in 1997 to 155.2 in 2010 per 100,000 inhabi-
tants [3]. Consequently, this population is very large and
growing, which stresses the importance of optimizing
the treatment offered to these patients. The QUADX-1
trial will add knowledge relating to which knee-extensor
strength exercise dosage is most effective in increasing
knee-extensor strength and whether a single, home-
based (unsupervised) knee-extensor strength exercise is
feasible in patients with end-stage knee OA.
The minimal treatment approach (single exercise) has
been chosen as it is a pragmatic and time-saving solution
[46]. Further, the rationale for investigating a home-based,
single knee-extensor strength exercise is that it could im-
prove exercise adherence as it is simple (minimal intellec-
tual effort), does not take a long time (requires less surplus
energy) and is likely to inflict less pain (less stress imposed
on the knee joint). An exercise targeting the knee-extensor
muscle is chosen as it is the single most important muscle
for function in the knee OA population [9, 10, 13, 14].
In summary, the objective of the QUADX-1 trial is to
investigate the efficacy of three different exercise dosages
of pre-operative, home-based, knee-extensor strength ex-
ercise before and shortly after surgery in patients eligible
for total knee replacement. The results will indicate which
knee-extensor strength exercise dosage is most effective
for increasing knee-extensor strength in the end-stage
knee OA population. Furthermore, the results will indicate
whether pre-operative knee-extensor strength exercise
improves knee-extensor strength and function prior to
surgery and whether this effect (if any) is sustained
following surgery.
Table 6 Regression models for supplementary analysis
Supplementary analyses (primary outcome at primary endpoint)
Dependent variable (y) Independent variable (x)
Linear regression model Change in isometric knee-extensor strength Δt0-t1 Exercise adherence
Seconds of total time-under-
tension (TUT)
Number of completed exercise
sessions
Supplementary analyses (secondary outcomes at primary and secondary endpoints)
Linear regression models Change in isometric knee-extensor strength Δt0-t2, Δt0-t3 Exercise adherence
Seconds of total time-under-
tension (TUT)
Number of completed exercise
sessions
Change in 6-minute walk test for distance (6MWT) Δt0-t1, t0-t2, t0-t3
Change in stair climb test (SCT) Δt0-t1, t0-t2, t0-t3
Change in Knee Osteoarthritis Outcome Score (KOOS)
subscales Δ t0-t1, t0-t3
Change in Oxford Knee Score (OKS) Δ t0-t1, t0-t3
Change in current knee pain (Numeric Rating Scale, NRS)
Δ t0-t1, t0-t2, t0-t3
Change in knee pain during the last week (Numeric
Rating Scale, NRS) Δ t0-t1, t0-t3
Need for surgery (yes/don’t know/no)
Averse events
Fig. 8 A hypothetical simple regression model with the change in
isometric knee-extensor strength (Nm/kg) at the primary endpoint
and time-under-tension (TUT)
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Strengths
The trial design has several strengths as it addresses
numerous gaps in the academic literature. Trials in-
vestigating the dose-response relationship of strength
exercise in patients with end-stage knee OA are rare.
Accordingly, there is a need for investigating the most
effective exercise dose in this patient population, as
highlighted in two recent systematic reviews using
meta-analysis [21, 22]. Peer et al. highlight the scarcity
of evidence related to exercise dose-response in pa-
tients with knee OA needed to guide pre-habilitation
in clinical practice [22]. Further, Bartholdy et al. sug-
gest that a 30–40% gain in knee-extensor strength is
needed to positively affect pain and disability in patients
with knee OA [21], highlighting the need for evidence to
suggest the exercise dosage required to obtain adequate
improvement in knee-extensor strength.
Adherence to home-based exercise is reported to be
low with a high risk of over-reporting [45–48]. The use
of sensors attached to the elastic exercise band will ad-
dress this in an objective manner. Further, in a recent
systematic review on adherence with physiotherapy
exercises it was requested that the relationship between
adherence and treatment outcome was investigated [46].
The exercise regimes currently offered to patients with
knee OA are mostly supervised exercise sessions at out-
patient clinics and comprise several exercises resulting
in accumulated time spent and cost. In this trial, a sin-
gle, simple, home-based exercise is applied, thus, investi-
gating whether an alternative exercise treatment, which
is simplified and maintained unsupervised at home,
might be offered to these patients.
This trial protocol follows the Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT)
Checklist (Fig. 2, Additional file 1) [24] and the exercise
intervention is reported according to the TIDieR Checklist
(Additional file 2) [26] allowing for replication and direct
clinical use, which has been requested in a recent review
[53]. The cross-sectional design mimics everyday practice
of cross-sector boarder communication increasing the
external validity for future clinical implementation.
Limitations
The trial has some limitations which must be taken into
consideration. There is no control group limiting the
inferences that can be made on the effect of the knee-
extensor strength exercise.
Due to the nature of the intervention (exercise) there
is a risk of selection bias, e.g., patients motivated for ex-
ercise are more likely to participate in the trial. This also
limits the external validity with respect the whole knee
OA population.
In the present trial design, the patients are asked about
their need for surgery after the 12-week exercise period. In
line with the above limitation, the answer to this question
could be biased as patients motivated for exercise might
be less motivated towards surgery affecting their answer
to need for surgery towards.
Though the sensor objectively measures activity with
the elastic exercise band, the sensor cannot measure
who is exercising, which muscle is exercised or what
movement is performed.
Finally, no recording or monitoring of the use of knee-
related pain medication during the trial is planned for.
Trial status
Protocol version no. 4.1 (21 November 2017). Inclusion
began 1 November 2016. Approximate date for inclusion
completion is 31 December 2019.
Additional files
Additional file 1: SPIRIT Checklist. (DOC 122 kb)
Additional file 2: TIDieR Checklist. (DOCX 31 kb)
Additional file 3: Patient brochure (English). (PDF 825 kb)
Additional file 4: Administrative information. (DOCX 38 kb)
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